Zusammmenfassung
Die Computertomographie (CT) ist heute breit verfügbar und stellt eine wichtige und schnelle Methode zur Diagnostik akuter Lebererkrankungen, der Artdiagnostik fokaler Leberläsionen und der Planung interventioneller Therapiemaßnahmen sowie der postinterventionellen Kontrolle dar. In den letzten Jahren hat die CT trotz des zunehmenden Stellenwerts der Magnetresonanztomographie (MRT) nicht an Bedeutung verloren. Durch den Einsatz unterschiedlicher Kontrastmittelphasen kann meist eine gute Charakterisierung von Raumforderungen erfolgen. Bei der Diagnostik des hepatozellulären Karzinoms (HCC) sollte beispielsweise immer ein triphasisches Untersuchungsprotokoll angewendet werden. Mit Einführung der Dual-energy-CT hat die Sensitivität in der Darstellung hyper- und hypovaskularisierter Leberläsionen zugenommen. Ebenfalls ist es durch virtuelle native Bilder möglich geworden, auf eine zusätzliche native Bildgebung zu verzichten, wodurch die Strahlenexposition des Patienten vermindert werden kann. Die PET/CT hat in der onkologischen Bildgebung den Vorteil, dass nahezu der gesamte Körper des Patienten abgebildet wird. Hier ist auch die Hauptindikation der PET/CT zu sehen (Ganzkörperstaging). Bei rein hepatischer Fragestellung hat die FDG-PET/CT unter Verwendung diagnostischer CT-Daten zwar eine höhere Genauigkeit als die CT alleine, ist der MRT jedoch unterlegen.
Abstract
Computed tomography (CT) is now widely available and represents an important and rapid method for the diagnostics of acute liver disease, characterization of focal liver lesions, planning of interventional therapy measures and postintervention control. In recent years CT has not become less important despite the increasing value of magnetic resonance imaging (MRI). By the use of different contrast medium phases good characterization of space-occupying lesions can be achieved. For the diagnostics of hepatocellular carcinoma (HCC) a triphasic examination protocol should always be implemented. The introduction of dual energy CT increased the sensitivity of imaging of hypervascularized and hypovascularized liver lesions and by the use of virtual native imaging it has become possible to avoid additional native imaging which reduces the x-ray exposition of patients. Positron emission tomography (PET) has an advantage for imaging in oncology because nearly the complete body of the patient can be screened and this is the main indication for PET/CT (whole-body staging). For purely hepatic problems 18F-fluorodeoxyglucose (FDG)-PET/CT using diagnostic CT data has a higher precision than CT alone but is inferior to MRI.
Literatur
Weg N, Scheer MR, Gabor MP (1998) Liver lesions: improved detection with dual-detector-array CT and routine 2.5 mm thin collimation. Radiology 209:417–426
Karçaaltıncaba M, Aktaş A (2010) Dual-energy CT revisited with multidetector CT: review of principles and clinical applications. Diagn Interv Radiol. DOI: 10.4261/1305-3825.DIR.3860-10.0
Altenbernd J, Heusner TA, Ringelstein A et al (2010) Dual-energy-CT of hypervascular liver lesions in patients with HCC: investigation of image quality and sensitivity. Eur Radiol [Epub ahead of print]
Park JH, Kim AH, Park HS et al (2010) Added value of 80 kVp images to averaged 120 kVp images in the detection of hepatocellular carcinomas in livertransplantation candidates using dual-source dual-energy MDCT: results of JAFROC analysis. Eur J Radiol [Epub ahead of print]
Robinson E, Babb J, Chandarana H, Macari M (2010) Dual source dual energy MDCT: comparison of 80 kVp and weighted average 120 kVp data for conspicuity of hypo-vascular liver metastases. Invest Radiol 45:413–418
Antoch G, Saoudi N, Kuehl H et al (2004) Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-d-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET. J Clin Oncol 22(21):4357–4368
Chan WC, Joe BN, Coakley FV et al (2006) Gallstone detection at CT in vitro: effect of peak voltage setting. Radiology 241(2):546–553
Boll TD, Merkle EM (2009) Diffuse liver disease: strategies for hepatic and MR imaging. Radiographics 29:1591–1614
Brink JA, Heiken JP, Forman HP et al (1995) Hepatic spiral CT: reduction of dose of intravenous contrast material. Radiology 197:83–88
Baron RL (1994) Understanding and optimizing use of contrast material for CT of the liver. AJR Am J Roentgenol 163:323–331
Awai K, Inoue M, Yagyu Y et al (2004) Moderate versus high concentration of contrast material for aortic and hepatic enhancement and tumor-to-liver contrast at multi-detector row CT. Radiology 233:682–688
Matoba M, Kitadate M, Kondou T et al (2009) Depiction of hypervascular hepatocellular carcinoma with 64-MDCT: comparison of moderate- and high concentration contrast material with and without saline flush. AJR Am J Roentgenol 193:738–744
Foley DW, Mallisee TA, Hohenwalter MD et al (2000) Multiphase hepatic CT with a multirow detector CT scanner. AJR Am J Roentgenol 175:679–685
Ichikawa T, Kitamura T, Nakajima H et al (2002) Hypervascular hepatocellular carcinoma: can double arterial phase imaging with multidetector CT improve tumor depiction in the cirrhotic liver? AJR Am J Roentgenol 179(3):751–758
Laghi A, Iannaccone R, Rossi P, Carbone I et al (2003) Hepatocellular carcinoma: detection with triple-phase multi-detector row helical CT in patients with chronic hepatitis. Radiology 226(2):543–549
Schima W, Kulinna C, Ba-Ssalamah A et al (2005) Multidetektor-CT (MDCT) der Leber. Radiologe 45:15–23
Guan Y, Zheng X, Zhou X et al (2004) Multidetector CT in evaluating blood supply of hepatocellular carcinoma after transcatheter arterial chemoembolization. World J Gastroenterol 10(14):2127–2129
Vogt FM, Antoch G, Veit P et al (2007) Morphologic and functional changes in nontumorous liver tissue after radiofrequency ablation in an in vivo model: comparison of 18F-FDG PET/CT, MRI, ultrasound, and CT. J Nucl Med 48(11):1836–1844
Atassi B, Bangash AK, Salem R et al (2008) Multimodality Imaging following 90Y radioembolization: a comprehensive review and pictorial essay. Radiographics 28:81–99
Marshall W, Hall E, Doost-Hoseini A et al (1984) An implementation of dual energy CT scanning. J Comput Assist Tomogr 8:745–749
Kalender WA, Perman WH, Vetter JR et al (1986) Evaluation of a prototype dual-energy computed tomographic apparatus. I. Phantom studies. Med Phys 13:334–339
Zhang L, Peng J, Wu S et al (2010) Liver virtual non-enhanced CT with dual-source, dual-energy CT: a preliminary study. Eur Radiol 20:2257–2264
De Cecco CN, Buffa V, Fedeli Y et al (2010) Dual energy CT (DECT) of the liver: conventional versus virtual unenhanced images. Eur Radiol 20:2870–2875
Petersilka M, Bruder H, Krauss B et al (2008) Technical principles of dual source CT. Eur J Radiol 68:362–368
Yeh BM, Shepherd JA, Wang ZJ et al (2009) Dual-energy and low-kVp CT in the abdomen. AJR Am J Roentgenol 193:47–54
Coursey CA, Nelson RC, Boll DT et al (2010) Dual-energy multidetector CT: how does it work, what can it tell us, and when can we use it in abdominopelvic imaging? Radiographics 30:1037–1055
Marin D, Nelson RC, Samei E et al (2009) Hypervascular liver tumors: low tube voltage, high tube current multidetector CT during late hepatic arterial phase for detection – initial clinical experience. Radiology 251(3)
Fletcher JG, Takahashi N, Hartman R et al (2009) Dual-energy and dual-source CT: is there a role in the abdomen and pelvis? Radiol Clin North Am 47:41–57
Veit-Haibach P, Treyer V, Strobel K et al (2010) Feasibility of integrated CT-liver perfusion in routine FDG-PET/CT. Abdom Imaging 35(5):528–536
Veit-Haibach P, Treyer V, Strobel K et al (2005) Detection and localization of prostate cancer: correlation of (11)C-choline PET/CT with histopathologic step-section analysis. J Nucl Med 46(10):1642–1649
Niekel MC, Bipat S, Stoker J et al (2010) Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment. Radiology 257(3):674–684
Bellomi M, Rizzo S, Travaini LL, Bazzi L et al (2007) Role of multidetector CT and FDG-PET/CT in the diagnosis of local and distant recurrence of resected rectal cancer. Radiol Med 112(5):681–690
Klingenstein A, Haug AR, Nentwich MM et al (2010) Whole-body F-18-fluoro-2-deoxyglucose positron emission tomography/computed tomography imaging in the follow-up of metastatic uveal melanoma. Melanoma Res 20(6):511–516
Niekel MC, Bipat S, Stoker J et al (2010)Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment. Radiology 257(3):674–684
Dirisamer A, Halpern BS, Schima W et al (2008) Dual-time-point FDG-PET/CT for the detection of hepatic metastases. Mol Imaging Biol 10(6):335–340
Soyka JD, Veit-Haibach P, Strobel K et al (2008) Staging pathways in recurrent colorectal carcinoma: is contrast-enhanced 18F-FDG PET/CT the diagnostic tool of choice? J Nucl Med 49(3):354–361
Buck AK, Stollfuss JC, Stahl A et al (2007) Nuklearmedizinische Diagnostik von Lebertumoren. Internist 248:21–29
Park JW, Kim JH, Kim SK et al (2008) Prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma. J Nucl Med 49:1912–1921
Sun L, Guan YS, Pan WM et al (2007) Positron emission tomography/computer tomography in guidance of extrahepatic hepatocellular carcinoma metastasis management. World J Gastroenterol 28;13(40):5413–5415
Yang SH, Suh KS, Lee HW, Cho EH et al (2006) The role of (18)F-FDG-PET imaging for the selection of liver transplantation candidates among hepatocellular carcinoma patients. Liver Transpl 12(11):1655–1660
Ho CL, Chen S, Yeung DW et al (2007)Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma. J Nucl Med 48(6):902–909
Talbot JN, Fartoux L, Balogova S et al (2010) Detection of hepatocellular carcinoma with PET/CT: a prospective comparison of 18F-fluorocholine and 18F-FDG in patients with cirrhosis or chronic liver disease. J Nucl Med 51(11):1699–1706
Antoch G, Vogt FM, Veit P et al (2005) Assessment of liver tissue after radiofrequency ablation: findings with different imaging procedures. J Nucl Med 46(3):520–525
Kuehl H, Antoch G, Stergar H et al (2008) Comparison of FDG-PET, PET/CT and MRI for follow-up of colorectal liver metastases treated with radiofrequency ablation: initial results. Eur J Radiol 67(2):362–371
Kim HO, Kim JS, Shin YM et al (2010) Evaluation of metabolic characteristics and viability of lipiodolized hepatocellular carcinomas using 18F-FDG PET/CT. J Nucl Med 51:1849–1856
Interessenkonflikt
Die korrespondierende Autorin gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Klasen, J., Heusner, T., Riegger, C. et al. Moderne CT- und PET/CT-Bildgebung der Leber. Radiologe 51, 671–679 (2011). https://doi.org/10.1007/s00117-010-2125-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00117-010-2125-3
Schlüsselwörter
- Multidetektorcomputertomographie (MDCT)
- Dual-energy-Computertomographie (DECT)
- Positronenemissionstomographie (PET)
- Hepatozelluläres Karzinom (HCC)
- Selektive interne Radiotherapie (SIRT)